查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球婦科藥物市場：按治療、適應症、分銷渠道和地區劃分的競爭、預測和機遇（2027 年）
市場調查報告書
商品編碼
1063911

全球婦科藥物市場：按治療、適應症、分銷渠道和地區劃分的競爭、預測和機遇（2027 年）

Global Gynecology Drugs Market, By Therapeutics, By Indication, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 199 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球婦科藥物市場預計將以 8.64% 的複合年增長率增長，2021 年達到 141.3956 億美元，到 2027 年達到 213.9567 億美元。

市場的主要驅動力是女性生活方式的顯著變化、各種婦科癌症和疾病的患病率增加、在線銷售渠道的引入以及有效治療方法的開發，其中包括大量的投資。

從銷售渠道來看，2021 年零售藥店以 48.39% 的份額引領全球市場。

本報告分析了全球婦科用藥市場，並詳細介紹了整體市場規模趨勢展望、市場份額結構（按治療方法、適應症類型、分銷渠道）、地區和主要國家。我們正在調查趨勢、主要市場促進/制約因素、企業間市場競爭格局、主要企業概況、未來市場增長方向。

目錄

第一章產品概述

第2章分析方法

第 3 章執行摘要

第 4 章客戶的看法

  • 品牌知名度
  • 影響購買決策的因素
  • 產品偏好：按治療

第5章COVID-19對全球婦科藥品市場的影響

第6章全球婦科藥物市場：未來展望

  • 市場規模及其預測
    • 金額基礎
  • 市場份額及其預測
    • 按治療方法（非激素療法、激素療法）
    • 按適應症（避孕、婦科感染、女性不孕症、絕經後障礙、多囊卵巢綜合徵、婦科癌症、子宮內膜異位症）
    • 按分銷渠道（零售藥店、醫院藥店、在線藥店）
    • 按地區（北美、歐洲、亞太地區、南美、中東/非洲）
    • 按公司 (2021)
  • 產品市場圖

第7章北美婦科藥物市場：未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 北美：國家/地區分析
    • 美國市場
    • 加拿大市場
    • 墨西哥市場

第8章歐洲婦科藥物市場：未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 歐洲：國家/地區分析
    • 德國市場
    • 法國市場
    • 英國市場
    • 意大利市場
    • 西班牙市場

第9章亞太婦科藥物市場：未來展望

  • 市場規模及其預測
  • 市場份額及其預測
  • 亞太地區：國家/地區分析
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場

第十章南美婦科藥物市場：未來展望

  • 市場規模及其預測
  • 市場份額及其預測
  • 南美洲：國家/地區分析
    • 巴西市場
    • 阿根廷市場
    • 哥倫比亞市場

第 11 章中東/非洲婦科藥物市場：未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 中東/非洲：國家/地區分析
    • 南非市場
    • 沙特阿拉伯市場
    • 阿拉伯聯合酋長國 (UAE) 市場

第12章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢和走勢

第14章競爭態勢

  • 公司簡介
    • Eli Lilly and Company Ltd.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Amgen Inc.
    • AstraZeneca Plc
    • F. Hoffmann-La Roche Ltd.
    • Allergan Plc.
    • Bayer AG
    • Abbott Laboratories Ltd.
    • AbbVie Inc.
    • GlaxoSmithKline Plc
    • Novartis Ltd.
    • Lupin Pharmaceuticals, Inc.
    • Johnson and Johnson Inc.
    • Sanofi SA

第 15 章戰略建議

Product Code: 7427

The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.

The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.

The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.

Major companies operating in the global gynecology market are: Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.

Years considered for this report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022
  • Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
  • To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
  • To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
  • To identify drivers and challenges for the global gynecology drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
  • To conduct pricing analysis for the global gynecology drugs market.
  • To identify and analyze the profile of leading players operating in global gynecology drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.

TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Gynecology drugs manufacturers/ suppliers/ distributors
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to gynecology drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.

Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Gynecology Drugs Market, By Therapeutics:

  • Non-Hormonal Therapy
  • Hormonal Therapy

Gynecology Drugs Market, By Indication:

  • Contraception
  • Gynecology Infections
  • Female Infertility
  • Postmenopausal disorders
  • Polycystic Ovary Syndrome
  • Osteoporosis
  • Gynecology Cancers
  • Endometriosis
  • Others (Urogenital Malformation, UTI & others)

Gynecology Drugs Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Gynecology Drugs Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness
  • 4.2. Factors Affecting Purchase Decision
  • 4.3. Product Preference, By Therapeutics

5. Impact of COVID-19 on Global Gynecology Drugs Market

6. Global Gynecology Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
    • 6.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
    • 6.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
    • 6.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 6.2.5. By Company (2021)
  • 6.3. Product Market Map

7. North America Gynecology Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapeutics
    • 7.2.2. By Indication
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gynecology Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapeutics
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Canada Gynecology Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapeutics
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Mexico Gynecology Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapeutics
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Distribution Channel

8. Europe Gynecology Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutics
    • 8.2.2. By Indication
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Gynecology Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapeutics
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. France Gynecology Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapeutics
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Gynecology Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapeutics
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Gynecology Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapeutics
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Gynecology Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapeutics
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Distribution Channel

9. Asia Pacific Gynecology Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutics
    • 9.2.2. By Indication
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Gynecology Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutics
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Japan Gynecology Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutics
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. India Gynecology Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutics
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Distribution Channel
    • 9.3.4. Australia Gynecology Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapeutics
        • 9.3.4.2.2. By Indication
        • 9.3.4.2.3. By Distribution Channel
    • 9.3.5. South Korea Gynecology Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapeutics
        • 9.3.5.2.2. By Indication
        • 9.3.5.2.3. By Distribution Channel

10. South America Gynecology Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutics
    • 10.2.2. By Indication
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gynecology Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutics
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Gynecology Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutics
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Gynecology Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutics
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Gynecology Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutics
    • 11.2.2. By Indication
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Middle East and Africa: Country Analysis
    • 11.3.1. South Africa Gynecology Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutics
        • 11.3.1.2.2. By Indication
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutics
        • 11.3.2.2.2. By Indication
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Gynecology Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutics
        • 11.3.3.2.2. By Indication
        • 11.3.3.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

  • 14.1. Company profiles
    • 14.1.1. Eli Lilly and Company Ltd.
    • 14.1.2. Pfizer Inc.
    • 14.1.3. Merck & Co., Inc.
    • 14.1.4. Amgen Inc.
    • 14.1.5. AstraZeneca Plc
    • 14.1.6. F. Hoffmann-La Roche Ltd.
    • 14.1.7. Allergan Plc.
    • 14.1.8. Bayer AG
    • 14.1.9. Abbott Laboratories Ltd.
    • 14.1.10. AbbVie Inc.
    • 14.1.11. GlaxoSmithKline Plc
    • 14.1.12. Novartis Ltd.
    • 14.1.13. Lupin Pharmaceuticals, Inc.
    • 14.1.14. Johnson and Johnson Inc.
    • 14.1.15. Sanofi SA

15. Strategic Recommendations

List of Figures

  • Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 5: Global Gynecology Drugs Market Share, By Region, By Value, 2017-2027F
  • Figure 6: Global Gynecology Drugs Market Share, By Company, By Value, 2021
  • Figure 7: Global Gynecology Drugs Market Map, By Therapeutics, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 8: Global Gynecology Drugs Market Map, By Indication, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 9: Global Gynecology Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 10: Global Gynecology Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 11: North America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 12: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 13: North America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 14: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 15: North America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 16: United States Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 17: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 18: United States Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 19: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 20: Canada Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 21: Fertility Rate in Canada, 2005, 2010, 2015, 2020
  • Figure 22: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 23: Canada Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 24: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 25: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 26: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 27: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 28: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 29: Europe Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 30: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 31: Europe Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 32: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 33: Europe Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 34: Germany Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 35: Fertility Rate in Germany, 2005, 2010, 2015, 2020
  • Figure 36: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 37: Germany Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 38: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 39: France Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 40: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 41: France Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 42: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 43: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 44: Prevalence of Menopause Symptoms Experienced by Women at Work in United Kingdom, 2021
  • Figure 45: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 46: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 47: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 48: Italy Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 49: Fertility Rate in Italy, 2005, 2010, 2015, 2020
  • Figure 50: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 51: Italy Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 52: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 53: Spain Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 54: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 55: Spain Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 56: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 57: Asia Pacific Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 58: Asia Pacific Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 59: Asia Pacific Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 60: Asia Pacific Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 61: Asia Pacific Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 62: China Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 63: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 64: China Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 65: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 66: Japan Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 67: Estimated Share of Women in Japan Using any Contraceptive Method, 2005, 2010, 2015, 2020
  • Figure 68: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 69: Japan Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 70: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 71: India Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 72: Polycystic Ovary Syndrome Issues Among Women Across India, By Age Group, 2020
  • Figure 73: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 74: India Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 75: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 76: Australia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 77: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 78: Australia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 79: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 80: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 81: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 82: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 83: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 84: South America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 85: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 86: South America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 87: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 88: South America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 89: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 90: Fertility Rate in Brazil, 2005, 2010, 2015, 2020
  • Figure 91: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 92: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 93: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 94: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 95: Total Female Population of Argentina, by Age Group, 2020 (in Millions)
  • Figure 96: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 97: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 98: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 99: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 100: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 101: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 102: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 103: Middle East & Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 104: Middle East & Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 105: Middle East & Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 106: Middle East & Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 107: Middle East & Africa Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 108: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 109: Fertility Rate in South Africa, 2005, 2010, 2015, 2020
  • Figure 110: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 111: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 112: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 113: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 114: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 115: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 116: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 117: UAE Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 118: Total Female Population of UAE, by Age Group, 2020 (in Millions)
  • Figure 119: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 120: UAE Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 121: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F

List of Tables

  • Table 1: Infertility Statistics of United States
  • Table 2: Ovary Cancer Cases in Mexico, 2020
  • Table 3: Ovary Cancer Cases in France, 2020
  • Table 4: Ovary Cancer Cases in Spain, 2020
  • Table 5: Ovary Cancer Cases in China, 2020
  • Table 6: Cancer Statistics of Australia, 2020
  • Table 7: Ovary Cancer Cases in South Korea, 2020
  • Table 8: Ovary Cancer Cases in Colombia, 2020
  • Table 9: Cervix Uteri Cancer Cases in Saudi Arabia, 2020